Study to Assess AFM24 in Combination With Atezolizumab in Selected Advanced/Metastatic EGFR-expressing Cancers

The Catholic University of Korea St. Vincent's Hospital, Suwon

Seoul National University Bundang Hospital, Seongnam-si

Johns Hopkins University, Baltimore

University Hospital Quiron Madrid, Madrid

University Clinic of Navarra - Pamplona, Pamplona

Hospital Clinic Universitario Biomedical Research institute INCLIVA, Valencia

University of Chicago Medical Center, Chicago

USC Norris Comprehensive Cancer Center, Los Angeles

Independent Public Teaching Hospital #4 in Lublin, Department of Clinical Oncology and Chemotherapy, Lublin

European Health Center Otwock Fryderyk Chopin Hospital, Department of Clinical Oncology, Otwock

MED-Polonia, Sp. z o.o. (LLC), Poznan

Janusz Korczak Provincial Specialist Hospital in Slupsk Limited Liability Company, Słupsk

Maria Sklodowska-Curie - National Research Institute of Oncology, Early Phase Research Department, Warsaw

Severance Hospital, Yonsei University Health System, Seoul

Vall d'Hebron Institute of Oncology (VHIO), Barcelona

Royal Marsden NHS Foundation Trust - ICR, Sutton